On the stock market since 2020, it operates in the world of health and science. It has 190 employees. Now — the numbers.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
There is growth, but not at top-of-the-class tempo.
The stock has been running stronger than the market lately.
Business Quality: Profit power and business quality trail similar companies in the sector.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
angles, checked one by one.
The 5 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades 31% below its peak. The market has trimmed its expectations for the company.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
This stock swings about 2.2 times as much as the market average. Big rallies — and big drops — can both happen fast.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 28/100.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 30/100.
On our five-subject report card, BFLY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BFLY is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.